SPDL1 and colorectal carcinoma: Kaplan-Meier survival analysis demonstrated that CRC patients with SPDL1-high transcript expression survived markedly longer than those with SPDL1-low (not reached vs. 67 months, 95% CI 48.3–86.3, p = 0.03; Figure 2B).